Effects of α-lipoic acid therapy on sympathetic heart innervation in patients with previous experience of transient takotsubo cardiomyopathy
- PMID: 26347218
- DOI: 10.1016/j.jjcc.2015.07.012
Effects of α-lipoic acid therapy on sympathetic heart innervation in patients with previous experience of transient takotsubo cardiomyopathy
Abstract
Background: Takotsubo syndrome is a stress cardiomyopathy, characterized by reversible left ventricle (LV) apical ballooning in the absence of significant angiographic coronary artery stenosis. The frequent association with emotional stress suggests in this disease an autonomic nervous system involvement. We could think that a therapeutic treatment targeting heart sympathetic dysfunction could be of crucial importance.
Methods: From January 2010 to June 2012, 886 patients were consecutively evaluated at Cardarelli Hospital, Naples, Italy. Among these, 48 patients met takotsubo cardiomyopathy (TCM) criteria. Each patient was assessed with history and physical examination, 12-lead electrocardiogram, serum troponin, coronary arteriography, and left ventricular angiogram, perfusion myocardial scintigraphy with technetium 99m, with echocardiography and 123I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy. At discharge, the surviving patients were randomly assigned to α-lipoic acid (ALA) treatment (600mg once daily) or placebo. Following discharge, after the initial TCM event, patients returned to our outpatient clinic at Internal Medicine of the Second University Naples for the follow-up evaluation quarterly until 12 months. Routine analysis, myocardial damage serum markers, oxidative stress serum markers, pro-inflammatory cytokines, and sympathetic tone activity were evaluated in all patients.
Results: ALA administration improved MIBG defect size at 12 months compared to placebo.
Conclusions: Adrenergic cardiac innervation dysfunction in TCM patients persists after previous experience of transient stress-induced cardiac dysfunction. ALA treatment improves the adrenergic cardiac innervation. This study evaluates whether sympatho-vagal alterations are TCM event-related.
Keywords: Nitric oxide; Sympathetic heart innervation; Takotsubo cardiomyopathy; α-Lipoic acid.
Copyright © 2015 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
Comment in
-
Divergence in the results of plasma catecholamine levels in different studies on patients with takotsubo syndrome: Why?J Cardiol. 2016 Jul;68(1):89. doi: 10.1016/j.jjcc.2015.10.009. Epub 2015 Nov 17. J Cardiol. 2016. PMID: 26597620 No abstract available.
-
A-lipoic acid therapy mediated amelioration of sympathetic heart denervation in patients with takotsubo syndrome.J Cardiol. 2016 Jun;67(6):572. doi: 10.1016/j.jjcc.2015.09.019. Epub 2015 Nov 18. J Cardiol. 2016. PMID: 26603324 No abstract available.
-
Author's reply.J Cardiol. 2016 Jul;68(1):89-90. doi: 10.1016/j.jjcc.2015.11.003. Epub 2016 Feb 15. J Cardiol. 2016. PMID: 26899276 No abstract available.
Similar articles
-
The natural history of takotsubo syndrome: a two-year follow-up study with myocardial sympathetic and perfusion G-SPECT imaging.Eur J Nucl Med Mol Imaging. 2017 Feb;44(2):267-283. doi: 10.1007/s00259-016-3575-2. Epub 2016 Dec 1. Eur J Nucl Med Mol Imaging. 2017. PMID: 27909770
-
Regional alterations in myocardial sympathetic innervation in patients with transient left-ventricular apical ballooning (Tako-Tsubo cardiomyopathy).J Nucl Cardiol. 2008 Jan-Feb;15(1):65-72. doi: 10.1016/j.nuclcard.2007.08.005. Epub 2007 Oct 29. J Nucl Cardiol. 2008. PMID: 18242481
-
Zumba-induced Takotsubo cardiomyopathy: a case report.J Med Case Rep. 2018 Jun 10;12(1):160. doi: 10.1186/s13256-018-1696-x. J Med Case Rep. 2018. PMID: 29885664 Free PMC article.
-
Takotsubo Cardiomyopathy presenting with different morphological patterns in the same patient: a case report and review of the literature.Cardiovasc Pathol. 2020 Jul-Aug;47:107204. doi: 10.1016/j.carpath.2020.107204. Epub 2020 Jan 15. Cardiovasc Pathol. 2020. PMID: 32169829 Review.
-
Exploring the Pathophysiology of Takotsubo Cardiomyopathy.Curr Cardiol Rep. 2017 Jun;19(6):53. doi: 10.1007/s11886-017-0865-7. Curr Cardiol Rep. 2017. PMID: 28439851 Review.
Cited by
-
Management of Takotsubo Syndrome: A Comprehensive Review.Cureus. 2020 Jan 3;12(1):e6556. doi: 10.7759/cureus.6556. Cureus. 2020. PMID: 32042529 Free PMC article. Review.
-
Epidemiology, pathogenesis, and management of takotsubo syndrome.Clin Auton Res. 2018 Feb;28(1):53-65. doi: 10.1007/s10286-017-0465-z. Epub 2017 Sep 15. Clin Auton Res. 2018. PMID: 28917022 Free PMC article. Review.
-
Epidemiology, Pathophysiology, Diagnosis, and Principles of Management of Takotsubo Cardiomyopathy: A Review.Med Sci Monit. 2023 Mar 6;29:e939020. doi: 10.12659/MSM.939020. Med Sci Monit. 2023. PMID: 36872594 Free PMC article. Review.
-
Stress cardiomyopathy as a cause of reverse redistribution with Tc-99m tetrofosmin regadenoson-rest myocardial perfusion imaging.J Nucl Cardiol. 2023 Feb;30(1):144-151. doi: 10.1007/s12350-021-02754-z. Epub 2021 Aug 18. J Nucl Cardiol. 2023. PMID: 34409573 No abstract available.
-
Isoprenaline modified the lipidomic profile and reduced β-oxidation in HL-1 cardiomyocytes: In vitro model of takotsubo syndrome.Front Cardiovasc Med. 2022 Aug 22;9:917989. doi: 10.3389/fcvm.2022.917989. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36072861 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous